Gonadotropin-releasing hormone analogue cotreatment does not preserve ovarian function in young women receiving cyclophosphamide-based chemotherapy: a prospective, multicenter, randomized trial.

Trial Profile

Gonadotropin-releasing hormone analogue cotreatment does not preserve ovarian function in young women receiving cyclophosphamide-based chemotherapy: a prospective, multicenter, randomized trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Cetrorelix (Primary) ; Triptorelin (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil
  • Indications Cancer; Ovulation disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2012 Official title amended as reported by Australian New Zealand Clinical Trials Registry.
    • 27 Oct 2011 Status changed from recruiting to completed.
    • 26 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top